| Literature DB >> 26601222 |
Rory N Pruitt1, Benjamin Schwessinger2, Anna Joe1, Nicholas Thomas3, Furong Liu3, Markus Albert4, Michelle R Robinson4, Leanne Jade G Chan5, Dee Dee Luu3, Huamin Chen3, Ofir Bahar3, Arsalan Daudi3, David De Vleesschauwer3, Daniel Caddell3, Weiguo Zhang3, Xiuxiang Zhao3, Xiang Li6, Joshua L Heazlewood5, Deling Ruan1, Dipali Majumder3, Mawsheng Chern1, Hubert Kalbacher7, Samriti Midha8, Prabhu B Patil8, Ramesh V Sonti9, Christopher J Petzold5, Chang C Liu10, Jennifer S Brodbelt11, Georg Felix4, Pamela C Ronald1.
Abstract
Surveillance of the extracellular environment by immune receptors is of central importance to eukaryotic survival. The rice receptor kinase XA21, which confers robust resistance to most strains of the Gram-negative bacterium Xanthomonas oryzae pv. oryzae (Xoo), is representative of a large class of cell surface immune receptors in plants and animals. We report the identification of a previously undescribed Xoo protein, called RaxX, which is required for activation of XA21-mediated immunity. Xoo strains that lack RaxX, or carry mutations in the single RaxX tyrosine residue (Y41), are able to evade XA21-mediated immunity. Y41 of RaxX is sulfated by the prokaryotic tyrosine sulfotransferase RaxST. Sulfated, but not nonsulfated, RaxX triggers hallmarks of the plant immune response in an XA21-dependent manner. A sulfated, 21-amino acid synthetic RaxX peptide (RaxX21-sY) is sufficient for this activity. Xoo field isolates that overcome XA21-mediated immunity encode an alternate raxX allele, suggesting that coevolutionary interactions between host and pathogen contribute to RaxX diversification. RaxX is highly conserved in many plant pathogenic Xanthomonas species. The new insights gained from the discovery and characterization of the sulfated protein, RaxX, can be applied to the development of resistant crop varieties and therapeutic reagents that have the potential to block microbial infection of both plants and animals.Entities:
Keywords: Bacteria; Rice; immune receptors
Year: 2015 PMID: 26601222 PMCID: PMC4646787 DOI: 10.1126/sciadv.1500245
Source DB: PubMed Journal: Sci Adv ISSN: 2375-2548 Impact factor: 14.136
Fig. 1raxX, a small ORF located upstream of the raxSTAB operon, is required for activation of XA21-mediated immunity.
(A) raxST, raxA, and raxB are encoded in a single operon. A 1.0-kb region upstream of raxST and a 1.7-kb region downstream of raxB were deleted in PXO99Δ1.0Sp and PXO99Δ1.7Sp, respectively. The raxX ORF is located ~0.4 kb upstream of raxST and in the opposite orientation. (B) TP309 (open bars) or XA21-TP309 (black bars) were inoculated by clipping with scissors dipped in Xoo suspensions. Bars indicate the mean lesion length ± SE measured 14 days after inoculation (n ≥ 14). The “*” indicates statistically significant difference from PXO99 using Dunnett’s test (α = 0.01). No statistical differences in lesion length were observed on TP309 inoculated with the different strains. The experiment was repeated at least three times with similar results. (C) XA21-TP309 rice leaves display water-soaked lesions 2 weeks after inoculation with the indicated strains. (D) Growth of PXO99 (□), PXO99ΔraxX (△), and PXO99ΔraxX(praxX) (○) in rice leaves inoculated as in (B). In planta bacterial growth analysis was carried out as described (). Bacterial quantification was determined as the number of colony-forming units (CFU) extracted per inoculated leaf. For the final data point, “*” indicates statistically significant difference from PXO99 using Dunnett’s test (α = 0.01, n = 4). The experiment was repeated twice with similar results.
Fig. 2RaxST sulfates RaxX on tyrosine 41.
(A) The predicted PAPS binding residue R35 of RaxST and Y41 of RaxX are required for activation of XA21-mediated immunity. TP309 (open bars) and XA21-TP309 (black bars) were inoculated with the indicated Xoo strains, and lesion lengths were measured 14 days later as described in Fig. 1B. Bars indicate the mean lesion length ± SE (n ≥ 14). The “*” indicates statistically significant difference from PXO99 using Dunnett’s test (α = 0.01). (B) Ultraviolet photodissociation (UVPD) mass spectrum of a tyrosine-sulfated peptide (HVGGGDsYPPPGANPK, 2–, m/z 770) from trypsin digestion of in vitro sulfated RaxX39. After incubation with Escherichia coli–expressed and purified His-RaxST, RaxX39 was digested with trypsin and analyzed by LC-UVPD-MS/MS in the negative nanoelectrospray mode to generate a, c, x, y, and z product ions, which are defined in the fragmentation key in the upper left corner of the spectrum. SO3 is retained on all product ions, allowing the sulfate modification to be localized to Y41. Neutral losses of SO3 from the precursor ion and charge reduced radical precursor ion are denoted as (M-2H-SO3)2− and (M-2H-SO3)1−•, respectively, in the spectrum. The ion labeled “m7” refers to the neutral loss of the sulfotyrosine side chain without additional fragmentation of the peptide backbone. Examination of extracted ion chromatograms of the sulfated and nonsulfated peptides suggests that the sulfated peptide is 100× lower in abundance than the nonsulfated peptide (see fig. S9). (C and D) RaxX-His proteins purified from PXO99(praxX-His) and PXO99ΔraxST(praxX-His) were analyzed by selected reaction monitoring-MS (SRM-MS) (fig. S8). Total peak areas (arbitrary units) were quantitated for sulfated (C) and nonsulfated (D) tryptic RaxX peptides covering Y41.
Fig. 3Sulfated RaxX triggers XA21-mediated defense responses.
(A) Amino acid sequence of RaxX from PXO99. RaxX derivative peptides of varying lengths were tested for their ability to activate XA21-dependent signaling. Sulfated peptides shown in black trigger XA21-mediated defense responses, whereas nonsulfated peptides and the sulfated peptide RaxX_18 shown in red do not (figs. S13 to S21). “EC50 value on Ubi::XA21” refers to the EC50 values determined by monitoring total ROS production over 3 hours after application of the RaxX protein and peptide derivatives (fig. S20) at different concentrations on Kitaake rice expressing XA21 under the control of the ubiquitin promoter (Ubi::XA21) (n = 6). (B) ROS production in leaves of Kitaake and Ubi::XA21 rice plants treated with H2O (mock), RaxX21-Y, or RaxX21-sY (250 nM) (n = 6). RLU, relative light units. (C) Ethylene production in leaves of Kitaake and Ubi::XA21 rice plants after 4 hours of treatment with H2O (mock), RaxX21-Y, or RaxX21-sY (1 μM). The “*” indicates statistically significant difference from mock treatment using Dunnett’s test (α = 0.01, n = 3). (D) Temporal changes in defense marker gene (Os04g10010, PR10b, and Os12g36830) expression in leaves of Kitaake and Ubi::XA21 rice plants treated with H2O (mock), RaxX21-Y, or RaxX21-sY (500 nM, n = 3). All data points depict means ± SE. These experiments were repeated at least three times with similar results.
Fig. 4Comparative genomics and mutational analyses identify key amino acids required for RaxX activity.
(A) Alignment of amino acid sequences of RaxX from PXO99 and IXO685. The region corresponding to RaxX21 is boxed. (B and C) RaxX from the field strain IXO685 does not trigger XA21-mediated immune response. (B) TP309 (open bars) and XA21-TP309 (black bars) were inoculated with the indicated Xoo strains, and lesion lengths were measured 14 days later as described in Fig. 1B. Bars indicate the mean lesion length ± SE (n ≥ 14). (C) ROS production in leaves of Kitaake (open bars) and Ubi::XA21 (black bars) rice plants treated with the indicated peptides (250 nM) or mock treatment. Bars depict mean RLU over 3 hours ± SE (n = 6). (D and E) RaxX point mutation analysis reveals that P44 and P48 are required for activation of XA21-mediated immune response. (D) TP309 (open bars) and XA21-TP309 (black bars) were inoculated with the indicated Xoo strains, and lesions were measured 14 days later as described in Fig. 1B. Bars indicate the mean lesion length ± SE (n ≥ 14). (E) ROS production in leaves of Kitaake (open bars) and Ubi::XA21 (black bars) rice plants treated with the indicated peptides (250 nM) or mock treatment. Bars depict average RLU ± SE (n = 6). For (B) to (D), the “*” indicates statistically significant difference from mock treatments using Dunnett’s test (α = 0.01). These experiments were repeated at least three times with similar results.